(BPT) - For anyone interested in healthy aging, it can seem overwhelming to keep up with the latest trends. The good news is, many trends today focus on holistic approaches aiming to support your body's natural processes.
The GBP/USD pair dropped to 1.3252, its lowest level since 11 May 2025, as a resurgent US dollar and disappointing UK economic data weighed on the pound.
Healthcare company Baxter International (NYSE:BAX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.3% year on year to $2.81 billion. On the other hand, next quarter’s revenue guidance of $2.87 billion was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $0.59 per share was 3.2% below analysts’ consensus estimates.
International Paper Co (IP) shares drop 7% after Q2 earnings miss estimates despite revenue growth. Adjusted EPS of $0.20 fell short by 51.1%, sparking investor concerns.
Marine transportation service company Kirby (NYSE:KEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $855.5 million. Its GAAP profit of $1.67 per share was 2.7% above analysts’ consensus estimates.
Amicus Therapeutics (FOLD) beats Q2 2025 revenue and EPS estimates, driven by strong growth in Galafold and Pompe disease therapies, sparking a 2.77% pre-market rally.
Balchem Corp (BCPC) reported Q2 2025 earnings in line with estimates, with revenue at $255.5M and EPS at $1.27. Shares rose slightly in pre-market trading.
Capital Clean Energy Carriers Corp (CCEC) missed Q2 2025 revenue and EPS estimates, with shares down 1.45% pre-market. Weak performance reflects industry challenges, but no major sell-off occurred.
Fast-food chain Shake Shack (NYSE:SHAK) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 12.6% year on year to $356.5 million. Its non-GAAP profit of $0.44 per share was 16.9% above analysts’ consensus estimates.
Commerce.com (BIGC) reported Q2 2025 results with mixed performance—revenue slightly missed estimates while EPS beat. Rebranding to Commerce.com and new AI partnerships aim for growth.
Building materials company Builders FirstSource (NYSE:BLDR) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 5% year on year to $4.23 billion. The company’s full-year revenue guidance of $15.2 billion at the midpoint came in 6.6% below analysts’ estimates. Its non-GAAP profit of $2.38 per share was 1.6% above analysts’ consensus estimates.
Corporate treasuries and spot ETFs are rapidly consolidating their hold on Ethereum (CRYPTO: ETH), with combined on-chain and off-chain holdings now surpassing $32 billion.
Laureate Education (NASDAQ:LAUR) beat Q2 2025 earnings and revenue estimates, raising full-year guidance. Stock rose modestly as strong enrollment in Mexico and Peru drives growth.
ATI Inc. reports mixed Q2 2025 earnings, with EPS beating estimates but revenue missing. Aerospace & defense sales surged, though stock dipped 8% pre-market. Boeing deal strengthens outlook.
Apple (AAPL) to report Q3 earnings on July 31, with expected EPS of $1.42 and revenue of $89.04B. Wedbush analyst maintains $270 price target and 0.50% annual dividend yield. Investors can earn $500/month with $1,206,009 investment, or $100/month with $241,244. Dividend yield changes with dividend payments and stock price fluctuations. AAPL shares closed at $209.05 on Wednesday.
Satellite radio and media company Sirius XM (NASDAQ:SIRI) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.8% year on year to $2.14 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $8.5 billion at the midpoint. Its GAAP profit of $0.57 per share was 26.3% below analysts’ consensus estimates.
Peabody Energy (NYSE: BTU) Q2 2025 results missed revenue and EPS estimates, causing a 7.8% pre-market drop. Operational improvements noted, but wider loss and revenue shortfall weigh on sentiment.
Stagwell Inc. (STGW) reported mixed Q2 2025 results, with EPS beating estimates and revenue slightly missing. Shares rose 2.13% pre-market on strong digital growth.
The Caviar Cruise strategy identifies high-quality stocks like Abbott Labs (ABT) with steady growth, strong ROIC, low debt, and reliable cash flow for long-term investors.
S&P Global (SPGI) beat Q2 2025 earnings with $3.755B revenue and $4.43 EPS, driving a 2.16% pre-market rise. Steady performance reflects strong demand for data services.
Apellis Pharmaceuticals (APLS) reported mixed Q2 2025 results, missing revenue estimates ($178.49M vs. $192.29M) but beating EPS (-$0.33 vs. -$0.49). Shares rose 4.58% pre-market as FDA approval for EMPAVELI® boosts future prospects.
Telecommunications and media company Comcast (NASDAQ:CMCSA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.1% year on year to $30.31 billion. Its non-GAAP profit of $1.25 per share was 5.9% above analysts’ consensus estimates.
Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.
